Effectiveness of Zonisamide in Alcohol Dependent Veterans
Effectiveness of Zonisamide in the Treatment of Alcohol Dependent Veterans
Sponsor: VA Office of Research and Development
Terminated
Funding ended prematurely
Other terminated trials from VA Office of Research and Development
- SCI · Phase EARLY_PHASE1 · Feb 2026
- Spinal Cord Injury · Phase NA · Dec 2025
- Anxiety Disorders · Phase NA · Nov 2025
- Anemia · Phase PHASE2 · Jul 2025
- Early Stage Lung Cancer (I and II) · Phase PHASE2 · Mar 2025
See all terminations from VA Office of Research and Development
Other Alcohol Use Disorder trials with similar outcome
This PHASE3 trial investigates Alcohol Use Disorder and is currently terminated or withdrawn. VA Office of Research and Development leads this study, which shows 14 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE3
▶ Show 9 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Nov 2019 — Jul 2020 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Apr 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE3
-
Dec 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
May 2017 — Nov 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .